Search

Author/Creator Fox, Robert

53. Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients. (10th October 2017)

Authors:
Plavina, Tatiana; Muralidharan, Kumar Kandadi; Kuesters, Geoffrey; Mikol, Daniel; Evans, Karleyton; Subramanyam, Meena; Nestorov, Ivan; Chen, Yi; Dong, Qunming; Ho, Pei-Ran; Amarante, Diogo; Adams, Alison; De Sèze, Jerome; Fox, Robert; Gold, Ralf; Jeffery, Douglas; Kappos, Ludwig; Montalban, Xavi...
Journal:
Neurology
Issue:
Volume 89:Number 15(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

55. Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial. Issue 10320 (8th January 2022)

Authors:
Bowman, Simon J; Fox, Robert; Dörner, Thomas; Mariette, Xavier; Papas, Athena; Grader-Beck, Thomas; Fisher, Benjamin A; Barcelos, Filipe; De Vita, Salvatore; Schulze-Koops, Hendrik; Moots, Robert J; Junge, Guido; Woznicki, Janice N; Sopala, Monika A; Luo, Wen-Lin; Hueber, Wolfgang
Journal:
Lancet
Issue:
Volume 399:Issue 10320(2022)
Page Start:
161
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

57. Seeking progress in disease modification in Parkinson disease. (September 2021)

Authors:
Lungu, Codrin; Cedarbaum, Jesse M.; Dawson, Ted M.; Dorsey, E. Ray; Faraco, Carlos; Federoff, Howard J.; Fiske, Brian; Fox, Robert; Goldfine, Andrew M.; Kieburtz, Karl; Macklin, Eric A.; Matthews, Helen; Rafaloff, Gary; Saunders-Pullman, Rachel; Schor, Nina F.; Schwarzschild, Michael A.; Sieber, ...
Journal:
Parkinsonism & related disorders
Issue:
Volume 90(2021)
Page Start:
134
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗